ALXN2030

· Alexion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ALXN2030, covering 2026-04-01 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety, PK/PD, and Immunogenicity Study of SC ALXN2030 in Healthy Participants [Phase 1]